About Embla Medical hf 
Embla Medical hf
Pharmaceuticals & Biotechnology
Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The Company's main markets are North America, Europe and Asia. It has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.
Company Coordinates 
Company Details
Grjothals 1-5 , REYKJAVIK None : 110
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Niels Jacobsen
Chairman of the Board
Dr. Kristjan Ragnarsson
Vice Chairman of the Board
Mr. Arne Boye Nielsen
Director
Ms. Gudbjorg Eggertsdottir
Independent Director
Dr. Svafa Gronfeldt
Independent Director
Revenue and Profits:
Net Sales:
1,484 Million
(Quarterly Results - Mar 2026)
Net Profit:
93 Million
Pharmaceuticals & Biotechnology
DKK 11,449 Million ()
22.00
NA
0.00%
0.42
9.51%
1.96






